Related Experiment Video
Updated: Jun 30, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Identification of hub genes in calcific aortic valve disease
Qian-Cheng Lai1, Jie Zheng2, Jian Mou3
1Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Sichuan Provincial People's Hospital, Chengdu, 610000, Sichuan, China.
Insights
Calcific aortic valve disease (CAVD) involves aortic valve calcification, leading to stenosis. This study identifies potential gene targets for early prevention and diagnosis of this growing health burden.
Area of Science:
- Cardiovascular Biology
- Genomics
- Translational Medicine
Background:
- Calcific aortic valve disease (CAVD) is a progressive heart valve disorder characterized by aortic valve calcification, stiffness, and dysfunction.
- CAVD affects aging populations and is associated with hypertension, dyslipidemia, smoking, and genetics, posing a significant health and economic burden.
- Currently, no effective medications exist to manage or delay CAVD progression, which inevitably leads to aortic stenosis.
Purpose of the Study:
- To identify key hub genes associated with the development of CAVD.
- To discover potential biological targets for the early prevention and diagnosis of CAVD.
- To provide a foundation for future research into therapeutic strategies for CAVD.
Main Methods:
- Utilized bioinformatics analysis of four publicly available microarray datasets (GSE12644, GSE51472, GSE77287, GSE233819) from the GEO database.
- Focused on datasets specifically related to Calcific Aortic Valve Disease (CAVD).
- Employed data mining techniques to identify significant gene expression patterns and hub genes.
Main Results:
- Identified specific hub genes implicated in the occurrence of CAVD.
- Provided preliminary evidence for novel biological targets relevant to CAVD.
- The findings lay the groundwork for further investigation into the molecular mechanisms of CAVD.
Conclusions:
- The study offers preliminary insights into potential therapeutic and preventive targets for CAVD.
- Identified hub genes may serve as biomarkers for early diagnosis or therapeutic intervention.
- This research supports the development of future biological studies aimed at combating CAVD.
Abstract:
Calcific aortic valve disease (CAVD) is a heart valve disorder characterized primarily by calcification of the aortic valve, resulting in stiffness and dysfunction of the valve. CAVD is prevalent among aging populations and is linked to factors such as hypertension, dyslipidemia, tobacco use, and genetic predisposition, and can result in becoming a growing economic and health burden. Once aortic valve calcification occurs, it will inevitably progress to aortic stenosis. At present, there are no medications available that have demonstrated effectiveness in managing or delaying the progression of the disease. In this study, we mined four publicly available microarray datasets (GSE12644 GSE51472, GSE77287, GSE233819) associated with CAVD from the GEO database with the aim of identifying hub genes associated with the occurrence of CAVD and searching for possible biological targets for the early prevention and diagnosis of CAVD. This study provides preliminary evidence for therapeutic and preventive targets for CAVD and may provide a solid foundation for subsequent biological studies.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Specific Gene Expression
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...

